209 related articles for article (PubMed ID: 35990703)
1. Superinduction of immunosuppressive glioblastoma extracellular vesicles by IFN-γ through PD-L1 and IDO1.
Jung MY; Aibaidula A; Brown DA; Himes BT; Cumba Garcia LM; Parney IF
Neurooncol Adv; 2022; 4(1):vdac017. PubMed ID: 35990703
[TBL] [Abstract][Full Text] [Related]
2. The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction.
Himes BT; Peterson TE; de Mooij T; Garcia LMC; Jung MY; Uhm S; Yan D; Tyson J; Jin-Lee HJ; Parney D; Abukhadra Y; Gustafson MP; Dietz AB; Johnson AJ; Dong H; Maus RL; Markovic S; Lucien F; Parney IF
Neuro Oncol; 2020 Jul; 22(7):967-978. PubMed ID: 32080744
[TBL] [Abstract][Full Text] [Related]
3. Use of heparin to rescue immunosuppressive monocyte reprogramming by glioblastoma-derived extracellular vesicles.
Himes BT; Fain CE; Tritz ZP; Nesvick CL; Jin-Lee HJ; Geiger PA; Peterson TE; Jung MY; Parney IF
J Neurosurg; 2023 May; 138(5):1291-1301. PubMed ID: 36115048
[TBL] [Abstract][Full Text] [Related]
4. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles.
Ricklefs FL; Alayo Q; Krenzlin H; Mahmoud AB; Speranza MC; Nakashima H; Hayes JL; Lee K; Balaj L; Passaro C; Rooj AK; Krasemann S; Carter BS; Chen CC; Steed T; Treiber J; Rodig S; Yang K; Nakano I; Lee H; Weissleder R; Breakefield XO; Godlewski J; Westphal M; Lamszus K; Freeman GJ; Bronisz A; Lawler SE; Chiocca EA
Sci Adv; 2018 Mar; 4(3):eaar2766. PubMed ID: 29532035
[TBL] [Abstract][Full Text] [Related]
5. HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling.
Arkhypov I; Özbay Kurt FG; Bitsch R; Novak D; Petrova V; Lasser S; Hielscher T; Groth C; Lepper A; Hu X; Li W; Utikal J; Altevogt P; Umansky V
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36113897
[TBL] [Abstract][Full Text] [Related]
6. Hypoxic glioblastoma-cell-derived extracellular vesicles impair cGAS-STING activity in macrophages.
Tankov S; Petrovic M; Lecoultre M; Espinoza F; El-Harane N; Bes V; Chliate S; Bedoya DM; Jordan O; Borchard G; Migliorini D; Dutoit V; Walker PR
Cell Commun Signal; 2024 Feb; 22(1):144. PubMed ID: 38389103
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth.
Lamano JB; Lamano JB; Li YD; DiDomenico JD; Choy W; Veliceasa D; Oyon DE; Fakurnejad S; Ampie L; Kesavabhotla K; Kaur R; Kaur G; Biyashev D; Unruh DJ; Horbinski CM; James CD; Parsa AT; Bloch O
Clin Cancer Res; 2019 Jun; 25(12):3643-3657. PubMed ID: 30824583
[TBL] [Abstract][Full Text] [Related]
8. Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma.
Zhai L; Ladomersky E; Dostal CR; Lauing KL; Swoap K; Billingham LK; Gritsina G; Wu M; McCusker RH; Binder DC; Wainwright DA
Brain Behav Immun; 2017 May; 62():24-29. PubMed ID: 28179106
[TBL] [Abstract][Full Text] [Related]
9. Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 Signaling.
Fleming V; Hu X; Weller C; Weber R; Groth C; Riester Z; Hüser L; Sun Q; Nagibin V; Kirschning C; Bronte V; Utikal J; Altevogt P; Umansky V
Cancer Res; 2019 Sep; 79(18):4715-4728. PubMed ID: 31337655
[TBL] [Abstract][Full Text] [Related]
10. Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells.
Chen YC; He XL; Qi L; Shi W; Yuan LW; Huang MY; Xu YL; Chen X; Gu L; Zhang LL; Lu JJ
Biochem Pharmacol; 2022 Mar; 197():114940. PubMed ID: 35120895
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes.
Beez CM; Haag M; Klein O; Van Linthout S; Sittinger M; Seifert M
J Nanobiotechnology; 2019 May; 17(1):72. PubMed ID: 31133024
[TBL] [Abstract][Full Text] [Related]
12. Indoleamine 2,3-dioxygenase 1 and programmed cell death-ligand 1 co-expression correlates with aggressive features in lung adenocarcinoma.
Kozuma Y; Takada K; Toyokawa G; Kohashi K; Shimokawa M; Hirai F; Tagawa T; Okamoto T; Oda Y; Maehara Y
Eur J Cancer; 2018 Sep; 101():20-29. PubMed ID: 30014971
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
14. Association of PD-L1 and IDO1 expression with JAK-STAT pathway activation in soft-tissue leiomyosarcoma.
Iwasaki T; Kohashi K; Toda Y; Ishihara S; Yamada Y; Oda Y
J Cancer Res Clin Oncol; 2021 May; 147(5):1451-1463. PubMed ID: 32951108
[TBL] [Abstract][Full Text] [Related]
15. Immune Checkpoint Inhibition in GBM Primed with Radiation by Engineered Extracellular Vesicles.
Tian T; Liang R; Erel-Akbaba G; Saad L; Obeid PJ; Gao J; Chiocca EA; Weissleder R; Tannous BA
ACS Nano; 2022 Feb; 16(2):1940-1953. PubMed ID: 35099172
[TBL] [Abstract][Full Text] [Related]
16. PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients: comparative study of primary and metastatic lesions.
Toda Y; Kohashi K; Yamada Y; Yoshimoto M; Ishihara S; Ito Y; Iwasaki T; Yamamoto H; Matsumoto Y; Nakashima Y; Mawatari M; Oda Y
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2607-2620. PubMed ID: 32388585
[TBL] [Abstract][Full Text] [Related]
17. Programmed death ligand 1 (PD-L1) plays a vital part in DC tolerogenicity induced by IFN-γ.
Švajger U; Tešić N; Rožman P
Int Immunopharmacol; 2021 Oct; 99():107978. PubMed ID: 34298399
[TBL] [Abstract][Full Text] [Related]
18. Kynurenine in IDO1
Ying X; Zheng X; Zhang X; Yin Y; Wang X
J Transl Med; 2024 Mar; 22(1):267. PubMed ID: 38468343
[TBL] [Abstract][Full Text] [Related]
19. IFN-γ and tumor gangliosides: Implications for the tumor microenvironment.
Dillinger B; Ahmadi-Erber S; Lau M; Hoelzl MA; Erhart F; Juergens B; Fuchs D; Heitger A; Ladisch S; Dohnal AM
Cell Immunol; 2018 Mar; 325():33-40. PubMed ID: 29402391
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles from human umbilical cord blood plasma modulate interleukin-2 signaling of T cells to ameliorate experimental autoimmune encephalomyelitis.
Kim S; Maeng JY; Hyun SJ; Sohn HJ; Kim SY; Hong CH; Kim TG
Theranostics; 2020; 10(11):5011-5028. PubMed ID: 32308765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
